Early research (Phase 1)Study completedNCT02945215
What this trial is testing
Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients
Who this might be right for
B-Cell Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 181